Suppr超能文献

血管重建为肝门部胆管癌患者带来短期和长期生存益处:一项回顾性多中心研究。

Vascular reconstruction provides short-term and long-term survival benefits for patients with hilar cholangiocarcinoma: A retrospective, multicenter study.

作者信息

Huang Yi-Xian, Xu Chao, Zhang Cheng-Cheng, Liu Guang-Yi, Liu Xing-Chao, Fan Hai-Ning, Pan Bi, Li Yuan-Cheng

机构信息

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

Department of Hepatobiliary Surgery, Liaocheng People's Hospital, Liaocheng 252000, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2024 Dec;23(6):595-603. doi: 10.1016/j.hbpd.2024.05.001. Epub 2024 May 22.

Abstract

BACKGROUND

In patients with hilar cholangiocarcinoma (HCCA), radical resection can be achieved by resection and reconstruction of the vasculature. However, whether vascular reconstruction (VR) improves long-term and short-term prognosis has not been demonstrated comprehensively.

METHODS

This was a retrospective multicenter study of patients who received surgery for HCCA with or without VR. Variables associated with overall survival (OS) and recurrence-free survival (RFS) were identified based on Cox regression. Kaplan-Meier curves were used to explore the impact of VR. Restricted mean survival time (RMST) was used for comparisons of short-term survival between the groups. Patients' intraoperative and postoperative characteristics were compared.

RESULTS

Totally 447 patients were enrolled. We divided these patients into 3 groups: VR with radical resections (n = 84); non-VR radical resections (n = 309) and non-radical resection (we pooled VR-nonradical and non-VR nonradical together, n = 54). Cox regression revealed that carbohydrate antigen 242 (CA242), vascular invasion, lymph node metastasis and poor differentiation were independent risk factors for OS and RFS. There was no significant difference of RMST between the VR and non-VR radical groups within 12 months after surgery (10.18 vs. 10.76 mon, P = 0.179), although the 5-year OS (P < 0.001) and RFS (P < 0.001) were worse in the VR radical group. The incidences of most complications were not significantly different, but those of bile leakage (P < 0.001) and postoperative infection (P = 0.009) were higher in the VR radical group than in the non-VR radical group. Additionally, the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) up to 7 days after surgery tended to decrease in all groups. There was no significant difference in the incidence of postoperative liver failure between the VR and non-VR radical groups.

CONCLUSIONS

Radical resection can be achieved with VR to improve the survival rate without worsening short-term survival compared with resection with non-VR. After adequate assessment of the patient's general condition, VR can be considered in the resection.

摘要

背景

在肝门部胆管癌(HCCA)患者中,通过血管切除和重建可实现根治性切除。然而,血管重建(VR)是否能改善长期和短期预后尚未得到全面证实。

方法

这是一项回顾性多中心研究,纳入了接受或未接受VR的HCCA手术患者。基于Cox回归确定与总生存期(OS)和无复发生存期(RFS)相关的变量。采用Kaplan-Meier曲线探讨VR的影响。使用受限平均生存时间(RMST)比较两组间的短期生存情况。比较患者的术中及术后特征。

结果

共纳入447例患者。我们将这些患者分为3组:行根治性切除的VR组(n = 84);不行VR的根治性切除组(n = 309)和非根治性切除组(我们将行VR的非根治性切除和不行VR的非根治性切除合并在一起,n = 54)。Cox回归显示,糖类抗原242(CA242)、血管侵犯、淋巴结转移和低分化是OS和RFS的独立危险因素。VR根治组与非VR根治组术后12个月内的RMST无显著差异(10.18对10.76个月,P = 0.179),尽管VR根治组的5年OS(P < 0.001)和RFS(P < 0.001)较差。大多数并发症的发生率无显著差异,但VR根治组的胆漏发生率(P < 0.001)和术后感染发生率(P = 0.009)高于非VR根治组。此外,术后7天内所有组的丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平均呈下降趋势。VR根治组与非VR根治组术后肝衰竭的发生率无显著差异。

结论

与不行VR的切除相比,VR可实现根治性切除以提高生存率且不恶化短期生存。在充分评估患者一般状况后,切除时可考虑VR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验